UA100553C2 - Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
- Google Patents
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"filedCriticalГосударственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAA201012691ApriorityCriticalpatent/UA100553C2/en
Publication of UA100553C2publicationCriticalpatent/UA100553C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to medicine, in particular to cardiology, and can be used for objective assessment of antianginal effect of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventriculardiastolic dysfunction.
UAA201012691A2010-10-262010-10-26Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
UA100553C2
(en)
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
Liquid formulation comprising propylene glycol and an inodilator, an angiotensin converting enzyme inhibitor or a combination of both; process to prepare it; kit; and method of treatment of heart disease and / or hypertension.
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
Method for objective estimation of benidipine effect in patients with coronary heart disease accompanied by stenocardia and arterial hypertension with left ventricular hypertrophy
Method of assessment of the effectiveness of treatment s-metoprolol patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
Method of assessment of the effectiveness of treatment s-amplodypinom patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
Method for assessing treatment efficacy of isosorbid dinitrate in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction